baber/WOPTO huggingface dataset:
Patent PT-968003-E (PT)
Inventor: STURM ALBERT
IPC: A61L2/00
Filed: 1998-02-27
Abstract: A water-soluble, solid contact lens care agent (1) having at least a first (2) and a second (3) compartment containing within the first compartment (2) at least one agent, in particular a protease, for removing or supporting the cleaning of metabolic deposits on a contact lens and within the second compartment (3) at least one agent being capable of neutralizing a contact lens disinfecting solution, characterized in that the first compartment (2) is dissolved faster within the contact lens disinfecting solution than the second compartment (3) and both compartments (2, 3) are simultaneously subjectable to the contact lens disinfecting solution.
Patent PT-940379-E (PT)
Inventor: VIGNALI GRAZIANO
IPC: C04B33/34
Filed: 1999-03-02
Abstract: Composition whereby ceramic manufactured articles, obtained by moulding a conventional ceramic mixture without added TiO2., are coloured from yellow to orange, said composition consisting of an aqueous solution of inorganic compounds or organic complexes of titanium and chromium combined with antimony or tungsten or mixtures thereof, in quantities corresponding to 2 to 6% by wt. Ti, 3 to 12% Sb (or 4 to 14% tungsten) and 0.2 to 2.5% chromium.
Patent PT-1016345-E (PT)
Inventor: ROBERT BLAUWART
IPC: A22C25/00
Filed: 1999-12-23
Abstract: Fillets of fish or meat are made from a slab of reconstituted flesh (38). The slab is cut into portions by vertical blades (35 and 36) applied from above, while a flat surface (37), which retracts by compressing a spring (41), holds the area between the blades. The blades are then replaced by a curved surface, which shapes the sides of the fillet.  An Independent claim is also included for apparatus for performing this process.
Patent PT-967207-E (PT)
Inventor: DHAINAUT ALAIN
IPC: C07D409/04
Filed: 1999-06-24
Abstract: Nitrone substituted imidazole derivatives (I) are new. Nitrone substituted imidazole derivatives (I) and their salts are new. W1 = aryl, 1-6C arylalkyl, heteroaryl or 1-6C heteroarylalkyl; R1 = 1-6C alkyl, 2-6C alkenyl, 2-6C alkynyl, aryl, cycloalkyl, 1-6C arylalkyl, 1-6C cycloalkylalkyl; R2 = H, 1-5C alkyl, aryl, 1-6C arylalkyl, cycloalkyl, 1-6C cycloalkylalkyl, heterocycloalkyl, 1-6C heterocycloalkylalkyl, heteroaryl, 1-6C heteroarylalkyl, 1-6C acyl, 1-6C alkylsulfonyl, arylsulfonyl, 1-6C arylalkylsulfonyl or 2-6C alkenyl. An Independent claim is also included for the preparation of (I).
Patent PT-1096968-E (PT)
Inventor: NIELSEN JAN WILLUM
IPC: A61M5/158
Filed: 1999-07-13
Abstract: The invention relates to a medical puncturing device comprising a rigid needle being at one end adapted for facilitating the puncturing and comprising at the opposite end a hub, the hub comprising a handle part and a shield part being pivotable in relation to the handle part and further comprising locking means on the shield part and the handle part, the locking means being adapted to interlock the shield and the handle part in a pivoted position of the shield part where the rigid needle is covered by this.
Patent PT-1098901-E (PT)
Inventor: DENIS ALEXIS
IPC: A61P31/04
Filed: 1999-07-20
Abstract: The invention concerns compounds of formula (I) wherein: X represents a (NH)a, CH2 or SO2 radical or an oxygen atom; a represents 0 or 1; Y represents a (CH2)m-(CH=CH)n-(CH2)o radical with m+n+o<=8, n=0 or 1; Ar represents an aryl or heteroaryl radical, optionally substituted; W represents a hydrogen atom or a halogen atom; Z represents a hydrogen atom or an acid residue, and their addition salts with acids. The compounds of formula (I) have antibiotic properties
Patent PT-1119673-E (PT)
Inventor: MANZOTTI CARLO
IPC: E04H6/18
Filed: 1999-10-04
Abstract: A carriage (4) for conveying vehicles in multistorey carparks comprises a front module (7) and rear module (7') which are separable, provided with independant motor systems and can operate on the front (52) and rear wheels (55), respectively, of a vehicle (50) so as to be able to lift it and transport it from a platform (1) of a translator elevator (100) to a floor (101) of stalls or of the entrance-exit room of a multistorey car park and vice versa.
Patent SG-45292-G (SG)
Title: Stable injectable pharmaceutical formulation for 1,4-dihydroxy-5,8-bis((2-(hydroxyethylamino)-ethyl)amino)anthraquinone,dihydrochloride
IPC: A61K31/135
Filed: 1992-04-24
Abstract: This disclosure describes stable injectable pharmaceutical formulations of NOVANTRONE TM .
Patent SG-71292-G (SG)
Title: Electronic timepiece with analogous display
IPC: G04B33/00
Filed: 1992-07-08
Abstract: The stator (10) of the motor serves as a single plate, not only for the rotor, wheels and spindles for hands, but also for the rocker (72), the pulling crank (70) and the setting pinion of the minutes wheel. The stator is shaped locally to form, on the one hand, a groove which guides the end of the setting stem (64) and, on the other hand, a boss (84) into which is driven a pin (82) serving as a spindle for the setting pinion (80).
Patent IE-32512-L (IE)
Title: Glyceryl esters
IPC: C07D209/28
Filed: 1968-04-09
Abstract: 1,229,865. Acetals and ketals of glyceryl esters. SCHERICO Ltd. 5 April, 1968 [10 April, 1967], No. 16478/68. Heading C2C. Novel cyclic acetals and ketals of Compounds I in which A is a fused benzene or pyridine ring; R<SP>1</SP> is H, alkyl, CF 3 , alkylthio or one or two halo; R<SP>2</SP> and R<SP>3</SP> are H or alkyl; R<SP>4</SP> is H, halo, OH, NO 2 , alkoxy or alkyl; R<SP>5</SP> is OH, alkyl, alkoxy, CF 3 , NO 2 , NH 2 , H, or mono or di-alkylamino; n is 0, 1, 2 or 3 and the dotted line is an optional bond and their salts are prepared (a) by reacting a compound YCH 2 X by known methods with a compound ZCO-C 6 H 4 -R<SP>1</SP> where X is a cyclic acetal or ketal of an α,# - dihydroxy ethyl group and Y and Z are reactive groups capable of condensing during reaction to leave the bridge X between CH 2 X and -C 6 H 4 R<SP>1</SP>, (b) by reacting a carboxylic acid LCOOH or functional derivative thereof with HOQ where Q is a cyclic acetal or ketal of -CH 2 CHOHCH 2 OH and L is the grouping XI or (c) where an indolinyl or aza indolinyl compound is obtained, by subsequent oxidation to the indole or azaindole compounds. The glyceryl esters themselves may be obtained by ring opening the cyclic acetals or ketals. Certain of these esters are claimed in application 51238/70 which is divided from this application. Intermediates isolated are cyanomethyl (5- methoxy - 2 - methyl - 3 - indolyl) - acetate prepared by reacting the appropriate acetic acid derivative with ClCH 2 CN; acetonyl, phenacyl, carbamoylmethyl and ethoxycarbonyl esters of (5- methoxy - 2 - methyl - 3 - indolyl) - acetate prepared in a similar way to the first-named intermediate; #,y - isopropylidenedioxypropyl (5- methoxy - 2 - methyl - 3 - indolyl) - acetate, prepared by reaction of 2,2 - dimethyl - 4 - hydroxymethyl 1,3 - dioxolan with the first-named intermediate; and cyanomethyl (5 - methoxy - 2 - methyl - 3 - indolyl) α- or # - propionate, butyrate and valerate prepared in a similar manner to the first-named intermediate. Pharmaceutical compositions for oral, rectal, topical or parenteral administration as antiinflammatory agents comprise the novel acetals and ketals in conjunction with suitable excipients.
[GB1229865A]
Patent IE-37499-L (IE)
Title: Ó-AMINO-p-HYDROXYPHENYLACETAMIDOCEPHALOSPORINS
IPC: A61K31/546
Filed: 1973-04-04
Abstract: 1358027 3 - Heterocyclic α - amino - phydroxybenzyl cephalosporins SMITHKLINE CORP 30 March 1973 [14 June 1972 15 Sept 1972] 15308/73 Heading C2A Novel α-amino-p-hydroxybenzyl cephalosporins having the Formula (I) and salts thereof, wherein R is 5-methyl-1,3,4- thiadiazol-2-yl or 1-methyl-5-tetrazolyl are prepared by (1) N-acylating a 7-aminocephalosporin compound of Formula (II) or a carboxyl-protected ester or alkali metal salt thereof, wherein X is -S-R and R is either as defined above or is a group -OCOCH 3 , with α-amino-p-hydroxyphenylacetic acid or an N-acylating active derivative thereof, the -OH and -NH 2 groups being protected if necessary, and (2) when R is the group -OCOCH 3 , reacting the product with a heterocyclic thiol: HS-R or an alkali metal salt thereof, in which R is as defined above in connection with Formula (I), followed by (3) removal of any protecting group or groups. The sequence of reactions (1) and (2) may be reversed, i.e. 7-aminocephalosporanic acid or its salt or ester being reacted at the 3- position with the said heterocyclic thiol followed by N-acylation of the product with α- amino-p-hydroxyphenylacetic acid or its active derivative, with subsequent removal of any protecting groups. Protective groups used are conventional amino-, hydroxy- and carboxyl-protecting groups which are removable by, e.g. hydrolysis or hydrogenolysis. The N-acylation is usually performed with the acid itself in the presence of a condensing agent, or with a typically activated derivative of the acid. The 3-position replacement may be effected by reacting the amino-protected cephalosporin or its alkali metal salt with the thiol or its salt, at a pH near neutrality in acetone or aqueous acetone at elevated temperature. The product may be recovered by slight acidification of the reaction mixture followed by extraction with an immiscible solvent. Since the compound (I) has both acidic and basic groups, its salts may be base- or acidaddition salts; alternatively the compound may be in zwitterionic form. The compounds (I) and their salts have broad spectrum anti-bacterial activity and may be made up into various pharmaceutical compositions (e.g. for oral or parenteral administration) with the aid of an appropriate carrier, diluent or excipient.
[GB1358027A]
Patent IE-850592-L (IE)
Title: Benzothiazoles and benzothiophenes
IPC: C07D333/62
Filed: 1985-03-07
Abstract: The invention relates to compounds of the general formula I <IMAGE> wherein R1 represents one up to and including four, the same or different substituents selected from alkyl(1-6 C), alkoxy(1-6 C), hydroxy, halogen, NO2+L, CF3 or the group -NR5R6, whereby two substituents taken together may also represent a methylene-dioxy group, X represents nitrogen or the group <IMAGE> n has the value 0, 1 or 2, R3 represents one of the moieties: <IMAGE> <IMAGE> the latter meaning of R3 (amide) only under the condition that for X is nitrogen the meaning of R1 is limited to substituents selected from hydroxy, alkoxy(1-6 C) and methylenedioxy, and R4, R5 and R6 represent hydrogen or alkyl(1-6 C), and pharmaceutically acceptable salts thereof, suitable in the treatment of heart failure.
[US4665206A]
Patent FI-812362-L (FI)
Inventor: PETTERSSON SUNE OESTER
IPC: F23D11/40
Filed: 1981-07-28
Abstract: Burners, for example oil burners, with a feed tube (12) and a burner retainer (13, 15) inserted into the same. The air stream in the feed tube is made to be affected by a retarding shield (20) positioned ahead of the burner retainer (13, 15) and having a central aperture for the flame and a substantially circularly surrounding gap (18) between the retarding shield (20) and the inner periphery of the feed tube, and by a flange (19) extending rectangularly inwards from said inner periphery and which is positioned in spaced relation to the retarding shield in the direction of flow of the air. The spacing between the retarding shield (20) and the flange (19) is adjustable.
Patent FI-820216-L (FI)
Inventor: SVENS RUNAR
IPC: B65G33/24
Filed: 1982-01-25
Abstract: A feeding device for a vertical tube conveyor supplying the goods towards the lower input end of the conveyor consists of at least one vertical feeding wing rotatable around the lower end of the conveyor, the wing having a vertical elongation from the lower end of the casing of the conveyor to or beyond the lowest end of the conveyor, said wing forming a helix curve running from one point close to the casing, the angle between the tangent of the curve and the direction of rotation along the major part of the curve being such that the tangential force from the wing does not counteract the feeding of the goods into the supplier.
Patent FI-831872-L (FI)
Inventor: BARBULESCU ADRIAN
IPC: B30B9/02
Filed: 1983-05-25
Abstract: The present invention relates to a system and a method of extraction liquid from a humid mass by compressing same. The system comprises a conduit of linear, circular or other shape through which the humid mass is displaced. The conduit is of rectangular cross-section, which cross-section can be constant or variable. Further, the conduit has perforated side walls along at least a liquid extraction working section of the conduit. The system further comprises elements which cause an axial pressure at the interior of the humid mass as well as a mechanism to displace at least one of the perforated side walls to convey the humid mass along the working section of the conduit in such a way as to generate between the interior surface of the perforated side walls and the humid mass a dynamic friction force which defines a pressure zone which is less than the axial pressure created by the pressure creating elements. This difference in pressure causes the liquid in the humid mass to flow out of the mass in a direction substantially transverse to the displacement direction of the humid mass and out through the perforated side walls of the conduit.
Patent FI-844091-L (FI)
Inventor: BRACKE JAMES W
IPC: C12P/
Filed: 1984-10-17
Abstract: Hyaluronic acid, a polysaccharide, is prepared in high yield from streptococcus bacteria by fermenting the bacteria under anaerobic conditions in a CO2-enriched growth medium, separating the bacteria from the resulting broth and isolating the hyaluronic acid from the remaining constituents of the broth. The bacteria may be grown free of endotoxins by filtering all ingredients through a 10K Millipore TM filter prior to inoculation of the medium and subsequently maintaining pyrogen-free conditions. Separation of the microorganisms from the polysaccharide is facilitated by killing the bacteria with trichloroacetic acid. After removal of the bacterial cells and concentration of the higher molecular weight fermentation products, the hyaluronic acid is isolated and purified by precipitation, resuspension and reprecipitation.
Patent IE-45420-L (IE)
Title: Functional proteins.
IPC: A23L11/00
Filed: 1977-06-01
Abstract: A,PROCESS FOR IMPROVING TIIE FUNCTIONAL PROPERTIES OF PROTEIN MATERIAL Protein-containing materials are treated at specified temperature and pH conditions for a suitable length of time to yield products which replace material such as egg solid and nonfat dry milk.
[CA1091079A]
Patent IE-841360-L (IE)
Title: Manganese dioxide particle water purifier
IPC: C02F1/28
Filed: 1984-05-30
Abstract: A water purifier consisting essentially of manganese dioxide particles having a 20 to 48 mesh size and macroscopic pores which are so large in size as to permit passage of water therethrough. The particles may have active sites of needle-like or columnar crystals of manganese dioxide on the surfaces thereof. A method for making such water purifier is also described.
[US4551254A]
Patent IE-841381-L (IE)
Title: Ironing apparatus
IPC: D06F81/00
Filed: 1984-06-01
Abstract: The invention relates to an ironing apparatus particularly for home use. <??>It consists of an ironing board (1a) supported by collapsible legs (17, 18) to which a box-shaped body (2) can be connected either fixedly or in a removable manner. This body (2) is provided with specific housings (2a, 14) suitable to accommodate a steam boiler (10) and an iron (15) respectively, interconnected to each other by a fluid passage duct (16). <??>It is also provided that said steam boiler may be either formed directly in one of the collapsible legs supporting the board or carried, in a substantially vertical position, by one of said legs. 
[EP0131547A2]
Patent IE-781509-L (IE)
Title: Antibacterial compositions
IPC: A61P31/04
Filed: 1978-07-26
Abstract: Oral antibacterial compositions comprising mixtures of phosphanilic acid and trimethoprim are described.
[US4125610A]
Patent IE-822259-L (IE)
Title: Anticaries composition
IPC: A61K6/90
Filed: 1982-09-16
Abstract: Improved protection against dental enamel caries is provided by applying to the teeth and gingivae an oral hygiene composition containing, in addition to a pharmaceutically acceptable fluoride compound, a sufficient quantity of a pharmaceutically acceptable zinc compound so that the ratio of zinc ion to fluoride ion is at least about 7:1 by weight.
Patent IE-822703-L (IE)
Title: Forehardened photographic elements and their use in¹radiography
IPC: G03C5/16
Filed: 1982-11-12
Abstract: Forehardened photographic elements, particularly radiographic elements, intended to produce silver images are disclosed including among hydrophilic colloid layers at least one emulsion layer containing thin tabular silver halide grains. When developed in less than 1 minute to produce a viewable silver image, these photographic elements exhibit increased covering power.
[US4414304A]
Patent IE-812827-L (IE)
Title: Hydraulically controlled loading of rolling machine
IPC: C07J71/00
Filed: 1981-12-02
Abstract: The invention refers to compounds having anti-inflammatory activity, characterized by the formula   <IMAGE> (I)  in the form of a stereoisomeric mixture or an epimer of the R or S type regarding the orientation of the substituents at the carbon atom in position 22, in which formula A is n-propyl or n-butyl and Z is hydroxyl or hydroxyl esterified with a fatty acid with a straight or branched hydrocarbon chain having 1-5 carbon atoms. The invention also refers to a process for the preparation of these compounds, a pharmaceutical preparation containing one of the compounds and a method for the treatment and control of inflammatory conditions.
Patent IE-883582-L (IE)
Title: Method for preparing high-purity crystalline lactulose, and the product obtained
IPC: C07H3/04
Filed: 1988-11-30
Abstract: A method for preparing high-purity crystalline lactulose and the product obtained by the method, which comprises crystallization from aqueous solutions at a temperature of 5-40 DEG C, the starting aqueous solution having a lactulose concentration of 50-80% w/w, a lactose concentration of less than 5% of the lactulose concentration by weight, a galactose concentration of less than 5% of the lactulose concentration by weight, and a concentration of other sugars of less than 4% of the lactulose concentration by weight.
Patent IE-930324-L (IE)
Title: PHOSPHORUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS, NEW¹INTERMEDIATES AND METHOD
IPC: C07F9/547
Filed: 1988-05-20
Abstract: Compounds which are useful as inhibitors of cholesterol biosynthesis and thus as hypocholesterolemic agents have the structure <IMAGE> including salts thereof, wherein R is OH, lower alkoxy or lower alkyl; R<x> is H or alkyl; X is -O- or -NH-; n is 1 or 2 Z is a hydrophobic anchor, such as <IMAGE> wherein the dotted lines represent optional double bonds. New intermediates used in preparing the above compounds, e.g. compounds in which the OH group is silane blocked, pharmaceutical compositions containing such compounds and a method for using such compounds to inhibit cholesterol biosynthesis are also provided.
[DE3817375A1]
Patent NO-761941-L (NO)
Inventor: BARD J C
IPC: A23B4/005
Filed: 1976-06-08
Abstract: orkokt bacon med lavt nitritinnhold.
Patent NO-812758-L (NO)
Inventor: BECHGAARD CARL CHRISTIAN
IPC: A01N25/02
Filed: 1981-08-14
Abstract: A carrier consisting of ethylene glycol, or another hygroscopic glycol, or another hygroscopic liquid in a composition containing a protective agent to be introduced into a porous substrate such as timber, particularly a boron-rich compound (at least 25% of B2O3, preferably at least 35% of B2O3). For penetration into wood as a preservative suppressing or preventing insecticidal or fungal attack, the glycol carrier penetrating the outer portion of the wood more quickly than an aqueous carrier.
Patent NO-813196-L (NO)
Inventor: BRICH ZDENEK
IPC: C07D457/04
Filed: 1981-09-21
Abstract: PCT No. PCT/CH81/00105 Sec. 371 Date Apr. 26, 1982 Sec. 102(e) Date Apr. 26, 1982 PCT Filed Sep. 23, 1981.The invention concerns a process for the isomerization of ergoline derivatives substituted in the 8 beta  position by an electron withdrawing radical to the corresponding 8 alpha  compounds by removal of the proton in the 8 alpha  position and by a following, separately effected, protonation.
Patent NO-822268-L (NO)
Inventor: SCHUPPISER JEAN-LUC
IPC: C08F18/08
Filed: 1982-06-30
Abstract: Latices of vinyl acetate polymers comprising particles having an average diameter between 0.05 and 1  mu m and being present in the latex at a concentration of between 10 and 70% by weight. The polymers have a glass transition temperature between -20 DEG  and 50 DEG  C. The latices also contain a protective colloid comprising a water-soluble polymer (a) containing at least one monomer selected from the group consisting of N-methylolacrylamide and N-methylolmethacrylamide and a water-soluble polymer (b) of ethylene glycol, the polymer (b) having a molecular weight between 1,000 and 50,000. The latices are prepared by polymerization in aqueous emulsion, in the presence of both an initiator and the above-reference protective colloid. The latices may be applied as binders in the manufacture of paints, glues, paper, textiles, floor coverings and mortar additives.
Patent NO-830593-L (NO)
Inventor: MATHER FRANK WATKINS III
IPC: A61M1/36
Filed: 1983-02-21
Abstract: An assembly (10) of a rigid shell expansible blood reservoir (20), heater (40), and hollow fibre membrane oxygenator (60) is integrated into a self-supporting unit. A visible concavity (22) closed by a flexible membrane (24) forms a variable volume liquid and air-tight blood reservoir (20) attached to a blood heater (40) which in turn is attached to a hollow fibre membrane oxygenator (60). The assembly stores, heats, oxygenates and purifies blood by passing oxygen through the lumens of a mat (70) of small diameter gas-permeable hollow fibres supported on a cylindrical core (68) as blood flows over the outside surfaces of the fibres in a small, easy to use, safe, integrated oxygenator (60) which avoids blood contact with ambient air as blood circulates through the assembly.
Patent NO-840145-L (NO)
Inventor: MUCHOWSKI JOSEPH M
IPC: C07D487/04
Filed: 1984-01-16
Abstract: Novel 5-(4-vinyl- or 4-ethynylbenzoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids represented by the formula  <IMAGE>  and the pharmaceutically acceptable, non-toxic alkyl esters and salts thereof, wherein R is vinyl or ethynyl, and Y is hydrogen, a lower alkyl group having from 1 to 6 carbon atoms, chloro or bromo.
Patent NO-841108-L (NO)
Inventor: COOKE MICHAEL DAVID
IPC: C07D205/09
Filed: 1984-03-21
Abstract: The present invention relates to certain penem derivatives of the general formula Iin which R represents a hydrogen atom or a carboxyl esterifying group, R<sup>1</sup> represents certain unsubstituted and substituted aromatic and heterocyclic groups, and R<sup>2</sup> represents a hydrogen atom, an unsubstituted or substituted alkyl or aryl group.The compound of formula I and salts thereof may be used in the treatment of bacterial infections in man and other animals.
Patent NO-870255-L (NO)
Inventor: ZSEGER LASZLO
IPC: A63F9/06
Filed: 1987-01-21
Abstract: PCT No. PCT/HU86/00030 Sec. 371 Date Jan. 15, 1987 Sec. 102(e) Date Jan. 15, 1987 PCT Filed May 15, 1986 PCT Pub. No. WO86/06976 PCT Pub. Date Dec. 4, 1986.The invention relates to a toy which has an annular frame with a curved, exposed interior surface. A small toy vehicle is movable by manually moving and orienting the frame, for rolling on wheels around the curved interior surface. A retaining tether attaches the toy vehicle to the frame to permit the wheels to leave the interior surface of the frame but not to separate it entirely from it. In the preferred embodiment a continuous channel is provided throughout the entire interior of the frame and a slit communicates between the interior channel and the exposed interior surface of the frame. One end of the tether is tied to the toy vehicle and the other end is tied to a bead retained within the channel and freely moving throughout the entire length.